https://biotechmorning.com/news/car-t-prevent-multiple-myeloma Biotech Morning en 2026-08-08T14:14:08.483Z What If You Could Kill Cancer Before It Even Starts? https://biotechmorning.com/news/gene-editor-delete-hepatitis-b Biotech Morning en 2026-08-08T14:13:23.426Z The Gene Editor That Might Actually Delete Hepatitis B https://biotechmorning.com/news/nih-visa-researchers-funding-blocked Biotech Morning en 2026-08-08T14:12:34.073Z NIH Is About to Slam the Door on Thousands of Foreign Scientists https://biotechmorning.com/news/biomarin-bmn-401-phase-3-failure-270-million Biotech Morning en 2026-08-08T14:11:50.029Z BioMarin Just Torched $270 Million on a Drug That Couldn't Deliver https://biotechmorning.com/news/merck-tulisokibart-split-phase-2-results Biotech Morning en 2026-08-08T14:11:07.709Z Merck's Drug Aced One Test and Bombed the Other. That Tells Us a Lot. https://biotechmorning.com/news/fda-moderna-flu-vaccine-rejection-vaccine-industry-impact Biotech Morning en 2026-08-08T14:10:21.709Z The FDA Just Picked a Fight With Moderna's Flu Shot. The Whole Vaccine Industry Is Watching. https://biotechmorning.com/news/melanoma-drug-fda-rejected-twice-approved Biotech Morning en 2026-08-08T14:09:37.527Z The Melanoma Drug the FDA Rejected Twice Just Got Approved https://biotechmorning.com/news/crispr-worst-nightmare-intellia-clinical-hold Biotech Morning en 2026-08-08T14:08:43.813Z CRISPR's Worst Nightmare Just Became Real https://biotechmorning.com/news/cdc-buried-covid-vaccine-effectiveness-report Biotech Morning en 2026-08-07T14:18:24.512Z The CDC Had Proof COVID Vaccines Work. Then It Buried the Report. https://biotechmorning.com/news/dexcom-stelo-otc-cgm-pediatric-approval Biotech Morning en 2026-08-07T14:17:43.937Z The Glucose Monitor That Just Skipped the Doctor's Office https://biotechmorning.com/news/epicrispr-gene-therapy-growing-muscle-fshd Biotech Morning en 2026-08-07T14:16:59.747Z The Gene Therapy That's Growing Muscle in Patients Who've Only Ever Lost It https://biotechmorning.com/news/servier-edgewise-muscular-dystrophy-acquisition Biotech Morning en 2026-08-07T14:16:19.883Z Servier Just Paid $2.65 Billion for a Drug That Hasn't Hit Phase 3 Results Yet https://biotechmorning.com/news/gilead-tubulis-5-billion-adc-acquisition-5 Biotech Morning en 2026-08-07T14:15:35.638Z Gilead Just Spent $5 Billion on a German Startup You've Never Heard Of https://biotechmorning.com/news/biogen-apellis-acquisition-ophthalmology-2 Biotech Morning en 2026-08-07T14:14:51.475Z Biogen's $5.6B Bet on Your Grandparents' Eyes https://biotechmorning.com/news/narcolepsy-orexin-agonist-orzeyful-fda-approval Biotech Morning en 2026-08-07T14:14:04.676Z The Drug That Treats Narcolepsy by Actually Fixing What's Broken https://biotechmorning.com/news/mrna-flu-vaccine-fda-approval-moderna Biotech Morning en 2026-08-07T14:13:12.928Z The Flu Shot Just Got Its Biggest Upgrade in Decades https://biotechmorning.com/news/100-percent-tariff-brand-name-drugs Biotech Morning en 2026-08-07T14:12:22.406Z The $0 Pill Just Got a 100% Tax